Deniz T. Ozyukseler

Kartal Dr. Lutfi Kirdar Training And Research Hospital
Kartal, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study.

Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study.

Journal: Journal of cancer research and clinical oncology

Published: April 05, 2023

Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group.

Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group.

Journal: Journal of cancer research and therapeutics

Published: December 13, 2022

Survival outcomes of patients with oligometastatic non-small cell lung cancer who were treated with radical therapy: a multicenter analysis.

Survival outcomes of patients with oligometastatic non-small cell lung cancer who were treated with radical therapy: a multicenter analysis.

Journal: Turkish journal of medical sciences

Published: August 29, 2022

Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy?

Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy?

Journal: Expert review of anticancer therapy

Published: May 11, 2022

FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer.

FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer.

Journal: Journal of chemotherapy (Florence, Italy)

Published: January 17, 2022

Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center's experience.

Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center's experience.

Journal: Journal of chemotherapy (Florence, Italy)

Published: May 25, 2021

Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer?

Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer?

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: May 07, 2021

Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab.

Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab.

Journal: International journal of clinical oncology

Published: February 22, 2021

Initial Ca 125 Value as a Predictive Marker for High-grade Serous Ovarian Cancer.

Initial Ca 125 Value as a Predictive Marker for High-grade Serous Ovarian Cancer.

Journal: Journal of the College of Physicians and Surgeons--Pakistan : JCPSP

Published: December 15, 2020

Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study.

Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study.

Journal: Journal of cancer research and clinical oncology

Published: October 03, 2020

Is the duration of castration resistance predictive for sequential treatment responses in the metastatic castration-resistant prostate cancer setting?

Is the duration of castration resistance predictive for sequential treatment responses in the metastatic castration-resistant prostate cancer setting?

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: August 28, 2020

Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences.

Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences.

Journal: European urology focus

Published: July 16, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026